Matthew H. Nissing, Paul H. Hayashi – 22 June 2005 – There are no data regarding hepatic lobe donation effects on donor life insurability. Two investigators called 10 agents of 10 different large life insurance companies. One investigator gave a fictitious profile: Caucasian man, 33 years old, nonsmoker, without medical problems (control profile [CP]). The other investigator used the same profile with a history of uncomplicated right lobe donation 12 months earlier (donor profile [DP]). Investigators asked for premium quotes on a $100,000 term life policy.

Georgia Kostopanagiotou, Kassiani Theodoraki, Ageliki Pandazi, Nikolaos Arkadopoulos, Konstantinos Kostopanagiotou, Vassilios Smyrniotis – 22 June 2005 – Liver transplantation has become a gold standard treatment for irreversible liver disease. Conventional measures of oxygenation are inadequate to understand the dynamics of regional oxygen metabolism during liver transplantation because they represent global markers of tissue dysoxia.

Michael Nalesnik – 22 June 2005

Tobias Schroeder, Massimo Malagó, Jörg F. Debatin, Mathias Goyen, Silvio Nadalin, Stefan G. Ruehm – 22 June 2005 – In order to compare the performance of “all‐in‐one” magnetic resonance imaging (MRI) and “all‐in‐one” multidetector computed tomography (MDCT) in the preharvest evaluation 25 potential living donors underwent both MRI and MDCT. MRI was performed on a high‐performance 1.5‐T scanner, computed tomography (CT) on a 4‐row multidetector‐scanner. Both scan protocols included angiography of the arterial and venous hepatic systems.

Thomas Decaens, Françoise Roudot‐Thoraval, Solange Bresson‐Hadni, Carole Meyer, Jean Gugenheim, Francois Durand, Pierre‐Henri Bernard, Olivier Boillot, Karim Boudjema, Yvon Calmus, Jean Hardwigsen, Christian Ducerf, Georges Philippe Pageaux, Sebastien Dharancy, Olivier Chazouilleres, Daniel Dhumeaux, Daniel Cherqui, Christophe Duvoux – 22 June 2005 – The actual impact of transarterial chemoembolization before liver transplantation (LT) for hepatocellular carcinoma (HCC) on patient survival and HCC recurrence is not known.

Thierry Thevenot, Claire Vanlemmens, Vincent Di Martino, Marie‐Claude Becker, Pierre‐Olivier Denue, Bernadette Kantelip, Solange Bresson‐Hadni, Bruno Heyd, Georges Mantion, Jean‐Philippe Miguet – 22 June 2005 – Liver involvement in hereditary hemorrhagic telangiectasia may lead to high‐output cardiac failure. Few data have been reported on orthotopic liver transplantation (OLT) for these patients. In this paper, we describe two patients treated by OLT as a salvage procedure for cardiac failure, and we review literature on this subject.

Kalpana Reddy, Susan Mallett, Tim Peachey – 22 June 2005

Rajiv Jalan, Sambit Sen, Christian Steiner – 22 June 2005

Jorge Reyes – 22 June 2005

Matthew Jacob, James D. Lewsey, Carlos Sharpin, Alexander Gimson, Mohammed Rela, Jan H.P. van der Meulen – 22 June 2005 – A model that can accurately predict post–liver transplant mortality would be useful for clinical decision making, would help to provide patients with prognostic information, and would facilitate fair comparisons of surgical performance between transplant units.